HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis and characterization of herpes simplex virus after its persistence in a lymphoblastoid cell line for 15 months.

Abstract
Infection of a human lymphoblastoid cell line (F-365 line containing Epstein-Barr viral capsid antigen, derived from an individual without overt signs of lymphoma, infectious mononucleosis, or leukemia) with herpes simplex virus (HSV), maintained and observed for 15 months, was characterized by the continuous production of infectious extracellular virus. By the 5th day postinfection 75% of the cells produced HSV antigen as detected by fluorescent antibody, and by the 10th day 90% did so; production continued through the 15th month. Only 11% of single isolated cells produced detectable infectious virus. HSV produced after the 3rd month formed smaller plaque in monolayer cell culture than did the parental virus. No antigenic or polypeptide change in the HSV was detected by crossed immunoelectrophoresis and sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis over the 15-month cultivation in F-365 cells. Cell susceptibility and HSV virulence did not appear to change. The HSV-lymphoblastoid cell culture provided a useful model in which to study long-term virus-cell interactions.
AuthorsL F Roumillat, P M Feorino, D D Caplan, P D Lukert
JournalInfection and immunity (Infect Immun) Vol. 29 Issue 2 Pg. 671-7 (Aug 1980) ISSN: 0019-9567 [Print] United States
PMID6260656 (Publication Type: Journal Article)
Chemical References
  • Antigens, Viral
Topics
  • Antigens, Viral (analysis)
  • Cell Line
  • Cell Survival
  • Electrophoresis, Polyacrylamide Gel
  • Humans
  • Immunoelectrophoresis
  • Lymphocytes (immunology, microbiology)
  • Neutralization Tests
  • Simplexvirus (immunology, isolation & purification)
  • Time Factors
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: